Table 3. Clinical characteristics of primary Flt3-ITD+ AML bone marrow samples.
Age at diagnosis, gender, French-American-British (FAB) AML classification, and cytogenetic profile are shown for each patient; N/A, not available. Percent of leukemic blast cells present in peripheral blood (PB) and bone marrow (BM) are also shown. Samples are listed in order of ascending case number.
| Patient | Age | Gender | FAB | Cytogenetics | % Blasts (PB) |
% Blasts (BM) |
|---|---|---|---|---|---|---|
| 047 | 47 | F | M4 | t(6,9)(p23;34) | 14 | 59 |
| 104 | 66 | F | M1 | Normal | 86 | 92 |
| 175 | 74 | F | N/A | Normal | 98 | 95 |
| 194 | 64 | F | M5 | t(6,11)(q27;q23) | 20 | 74 |
| 289 | 70 | M | N/A | Normal | 62 | 70 |
| 332 | 46 | M | M4 | Normal | 83 | 86 |
| 410 | 54 | M | N/A | Normal | 74 | 79 |
| 454 | 69 | F | N/A | Complex | 44 | 53 |
| 488 | 82 | M | N/A | Normal | 21 | 65 |
| 490 | 65 | M | N/A | t(2;12)(p13;p13) | 83 | 96 |
| 515 | 48 | F | N/A | Normal | 90 | 72 |
| 548 | 69 | F | N/A | Normal | 86 | 96 |